(CIDRAP News) FluLaval has become the fifth influenza vaccine licensed by the US Food and Drug Administration (FDA) for use during the upcoming flu season, the FDA announced today.
FluLaval, produced by ID Biomedical Corp. of Quebec, a subsidiary of GlaxoSmithKline (GSK), has been marketed in Canada under the brand name Fluviral since 2001. It was granted fast-track review status by the FDA in July 2005.